Table 3.
Study | Quality assessment domains | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | |
de Sousa et al. [52, 38] | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 2 | 1 |
Lai et al. [37, 39] | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 2 | 1 |
Monse et al. [22, 24] | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 2 | 1 | 2 | 2 |
Yusof et al. [50, 36] | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 2 | 1 |
Key: 1 Yes; 2 No; 3 Unclear
Domain 1: Were the two groups similar and recruited from the same population?
Domain 2: Were the exposures measured similarly to assign people to both exposed and unexposed groups?
Domain 3: Was the exposure measured in a valid and reliable way?
Domain 4: Were confounding factors identified?
Domain 5: Were strategies to deal with confounding factors stated?
Domain 6: Were the participants free of the outcome at the start of the study?
Domain 7: Were the outcomes measured in a valid and reliable way?
Domain 8: Was the follow up time reported and long enough for outcomes to occur?
Domain 9: Was follow up complete, and if not, were the reasons to loss to follow up described and explored?
Domain 10: Were strategies to address incomplete follow up utilized?
Domain 11: Was appropriate statistical analysis used?